Now scheduling Illinois patients. Schedule Your Appointment →
Schedule Your Appointment
Now accepting Illinois patients · Brand-name GLP-1 prescription managementGet started →
Illinois GLP-1 telehealth
Nuu Metabolic patient
Telehealth visit
Provider consultation

The weight isn’t
the problem.
The plan is.

Clinician-led brand-name GLP-1 prescription management for Illinois adults. One provider. Real follow-up. No guesswork.

Check my eligibility →See how it works ↓
✦FDA-approved brand-name GLP-1 only
✦Illinois-licensed PA-C
✦Prior authorization support
✦HIPAA-compliant telehealth
✦One provider every visit
✦Transparent pricing · no surprise fees
✦Wegovy · Zepbound · Ozempic · Mounjaro · Rybelsus
✦Now scheduling Illinois patients
✦FDA-approved brand-name GLP-1 only
✦Illinois-licensed PA-C
✦Prior authorization support
✦HIPAA-compliant telehealth
✦One provider every visit
✦Transparent pricing · no surprise fees
✦Wegovy · Zepbound · Ozempic · Mounjaro · Rybelsus
✦Now scheduling Illinois patients
The difference

Why patients choose Nuu.

Most GLP-1 platforms send a prescription and disappear. Nuu is built differently — from the first visit to the last refill.

One Provider, Every Visit
Urooj is your provider at every appointment. No rotating staff. No starting over. No re-explaining your history.
Built From 15 Years of Frontline Medicine
Clinical judgment shaped by emergency medicine — not a wellness algorithm. Every decision grounded in real experience.
Medication Is One Tool — Not the Whole Plan
Lab strategy, lifestyle framework, and titration are all part of your care. A prescription without context isn’t treatment.
Transparent Pricing, No Bundled Medication Claims
Membership covers clinical care. Medications, labs, and pharmacy costs are always billed separately. No hidden fees.
What we prescribe

Brand-name GLP-1 — nothing else.

FDA-approved branded medications routed through your local pharmacy, with prior authorization support. No compounded. No gray-market substitutes.

FDA-approved for chronic weight management
Wegovy semaglutide injection
Semaglutide · weekly injection
Wegovy
The most studied GLP-1 for weight management. Once-weekly subcutaneous injection.
Zepbound tirzepatide injection
Tirzepatide · weekly injection
Zepbound
Dual GIP/GLP-1 receptor agonist. Strong clinical trial results for weight and metabolic health.
Foundayo orforglipron oral tablet
Orforglipron · daily oral tablet
Foundayo
The first non-peptide oral GLP-1, approved April 2026. No injection, and no food or water timing rules.
FDA-approved for type 2 diabetes — prescribed off-label for weight when clinically appropriate
Ozempic semaglutide injection
Semaglutide · weekly injection
Ozempic
The same molecule as Wegovy, approved for type 2 diabetes.
Mounjaro tirzepatide injection
Tirzepatide · weekly injection
Mounjaro
The same molecule as Zepbound, approved for type 2 diabetes.
Rybelsus oral semaglutide tablet
Semaglutide · daily oral tablet
Rybelsus
Once-daily oral semaglutide, approved for type 2 diabetes.

Off-label prescribing is legal, common, and evidence-guided. Whether any medication is appropriate for you is determined at your clinical visit — a prescription is never guaranteed.

Beyond the prescription

GLP-1 works best when
everything else is working too.

Six factors that determine whether GLP-1 delivers lasting results — and why clinical oversight matters more than just the medication.

Protein & Muscle
Without guidance, GLP-1 patients lose muscle alongside fat.
Insulin & Metabolic Health
The underlying driver of weight resistance — not just calories.
Sleep & Stress
Elevated cortisol directly undermines what GLP-1 is trying to do.
Optimal Exercise
Wrong training type accelerates muscle loss on GLP-1.
Dose & Titration
How fast you escalate determines whether you tolerate the medication or quit it.
Labs & Risk Factors
What to watch, when to adjust, and what the numbers mean.
See your potential

What could the next year look like?

Enter a few details to see the reduction range observed in GLP-1 clinical trials, mapped to a realistic timeline. Illustrative only — not a prediction or guarantee.

Interactive weight-trajectory tool

Reduction goal15%

5%20%
Potential weight at your goal

170 lbs
about 30 lbs lighter at 15%
In trials, most people saw a 5–20% reduction — for you that’s roughly 160–190 lbs.
Shaded band = 5–20% reduction range observed in trials. Line = your selected goal over ~16 months.
BMI now
32.3
obesity range
BMI at your goal
27.4
overweight
Even a 5–10% reduction is linked to meaningful improvements in blood pressure, blood sugar, and cholesterol.
What to expect, and when
Weeks 1–2
Appetite and food noise often quiet down
Weeks 4–8
First measurable changes typically begin
Months 3–12+
Trial-average range builds gradually
Ongoing
Maintenance planned with your provider

Schedule Your Appointment →

Illustrative preview, not a prediction. Figures reflect average results in GLP-1 trials (STEP-1: semaglutide ~15%; SURMOUNT-1: tirzepatide ~22.5% at 68–72 weeks) when used with clinical care. Individual results vary and are not guaranteed. Medication and eligibility are determined by your provider when clinically appropriate.

Three ways to work with Nuu.

A paid educational guide, or brand-name GLP-1 prescription management when clinically appropriate. Every plan begins with a $99 initial consultation.

See plans & pricing

Urooj Mujtaba PA-C Founder Nuu Metabolic
Founder & Lead Provider
“After 15 years in medicine — a decade of it in the ER — I built the practice traditional medicine never gave you.”
“My goal is not to react to your health problems. It is to see them coming — and to provide the personalized care that high-volume clinics simply can’t offer.”
— Urooj Mujtaba, PA-C
PA-CBoard certified
15+Years clinical
ILState licensed
DEAActive license
Simple by design

From first visit to first prescription.

01
Schedule your visit to get started
02
Meet with Urooj via telehealth
03
Prescription sent · prior auth prepared
04
Monthly check-ins and ongoing care

If prescribed, we prepare and submit your prior authorization. Coverage decisions are made by your insurer.

Watch
How GLP-1 medications actually work in your body
A plain-language explanation from Urooj — appetite signaling, insulin response, and why these medications work differently than anything before.

Visit Resources →

Quick answers

The three questions
everyone asks first.

Do I qualify for a GLP-1 prescription?+
FDA guidelines support GLP-1 prescribing for adults with a BMI ≥ 30, or BMI ≥ 27 with a weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol. BMI alone doesn’t determine eligibility — your full clinical picture does. Illinois residents 18+ only.
What does the medication actually cost?+
Medication is billed separately from your Nuu membership. With commercial insurance, many patients pay $0–$25/month through manufacturer savings programs. Without insurance, brand-name GLP-1 medications typically run $900–$1,400/month.
Is this a real prescription from a real provider?+
Yes. Urooj Mujtaba, PA-C holds an active Illinois PA license and DEA license. Every prescription is issued after a real clinical evaluation — not a form or a quiz. Prescriptions are sent to your local or mail-order pharmacy.

Your best health is
still ahead of you.

Clinician-led GLP-1 care for Illinois adults. One provider. Real follow-up.

Check my eligibility →

Already on a GLP-1 with another provider?

The Nuu Guide is the full optimization protocol — protein targets, muscle preservation, side-effect management, plateaus, and maintenance. $79, one-time, available anywhere.

Get the Nuu Guide — $79

Educational only. Does not include medical care, prescription management, or provider messaging.

Scroll to Top